Ligand-Targeted Liposomes for Cancer Treatment
Journal:
Current Drug Delivery
Volume:
2
Page:
369-381
Author(s):
Puja Sapra, Pradeep Tyagi and Theresa M. Allen
DNA Mismatch Repair Deficiency, Resistance to Cancer Chemotherapy and the Development of Hypersensitive Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1133-1149
Author(s):
Klaus Pors and Laurence H. Patterson
Endothelin-1 and Angiogenesis in Cancer
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
309-314
Author(s):
Jonathan Knowles, Marilena Loizidou and Irving Taylor
Cannabinoids
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
507-530
Author(s):
Franjo Grotenhermen
New Immunosuppressants: Immunosuppression and Immunomodulation
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
429-445
Author(s):
Anlun Ma, Jun Ouyang and Huifang Chen
The Plant-Type Ferredoxin-NADP+ Reductase/Ferredoxin Redox System as a Possible Drug Target Against Apicomplexan Human Parasites
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3159-3172
Author(s):
F. Seeber, A. Aliverti and G. Zanetti
Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
381-392
Author(s):
Rudolf Lucas, Matthias Kresse, Markus Latta and Albrecht Wendel
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
393-419
Author(s):
Christian Hafner, Albrecht Reichle and Thomas Vogt
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
Synergistic Approaches to Clinical Oncology Biomarker Discovery
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1047-1051
Author(s):
Stanley M. Belkowski, Deborah Polkovitch and Michael R. D'Andrea